Senores Pharmaceuticals Limited has informed the Exchange regarding Update in respect of intimations dated March 11, 2025 and March 12, 2025, pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( Listing Regulations ).
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Senores Pharmaceuticals has submitted an update to the stock exchange regarding two earlier disclosures made on March 11, 2025 and March 12, 2025. These earlier filings were originally submitted under SEBI's Regulation 30, which requires listed companies to disclose material events or information. The specific details of the original intimations and the nature of this update are not provided in the current filing and would need to be reviewed separately. Shareholders should refer to the earlier announcements dated March 11 and March 12 for full context.
This filing by itself does not indicate any new material event; investors should look up the original March 11 and March 12, 2025 announcements to understand the underlying matter and assess any potential impact on the stock.